rs1665894

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000521.4(HEXB):​c.558+45G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.907 in 1,003,202 control chromosomes in the GnomAD database, including 413,969 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.89 ( 60329 hom., cov: 33)
Exomes 𝑓: 0.91 ( 353640 hom. )

Consequence

HEXB
NM_000521.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -1.08

Publications

9 publications found
Variant links:
Genes affected
HEXB (HGNC:4879): (hexosaminidase subunit beta) Hexosaminidase B is the beta subunit of the lysosomal enzyme beta-hexosaminidase that, together with the cofactor GM2 activator protein, catalyzes the degradation of the ganglioside GM2, and other molecules containing terminal N-acetyl hexosamines. Beta-hexosaminidase is composed of two subunits, alpha and beta, which are encoded by separate genes. Both beta-hexosaminidase alpha and beta subunits are members of family 20 of glycosyl hydrolases. Mutations in the alpha or beta subunit genes lead to an accumulation of GM2 ganglioside in neurons and neurodegenerative disorders termed the GM2 gangliosidoses. Beta subunit gene mutations lead to Sandhoff disease (GM2-gangliosidosis type II). Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2014]
HEXB Gene-Disease associations (from GenCC):
  • Sandhoff disease
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P, ClinGen, Genomics England PanelApp, Myriad Women’s Health

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BP6
Variant 5-74696784-G-A is Benign according to our data. Variant chr5-74696784-G-A is described in ClinVar as [Benign]. Clinvar id is 256360.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.918 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HEXBNM_000521.4 linkc.558+45G>A intron_variant Intron 4 of 13 ENST00000261416.12 NP_000512.2 P07686A0A024RAJ6
HEXBNM_001292004.2 linkc.-118+45G>A intron_variant Intron 4 of 13 NP_001278933.1 P07686Q5URX0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HEXBENST00000261416.12 linkc.558+45G>A intron_variant Intron 4 of 13 1 NM_000521.4 ENSP00000261416.7 P07686
HEXBENST00000511181.5 linkc.-118+45G>A intron_variant Intron 4 of 13 1 ENSP00000426285.1 Q5URX0
HEXBENST00000510820.1 linkn.277+45G>A intron_variant Intron 2 of 3 3
HEXBENST00000513079.5 linkn.623+45G>A intron_variant Intron 4 of 5 2

Frequencies

GnomAD3 genomes
AF:
0.889
AC:
135267
AN:
152080
Hom.:
60279
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.844
Gnomad AMI
AF:
0.948
Gnomad AMR
AF:
0.824
Gnomad ASJ
AF:
0.909
Gnomad EAS
AF:
0.857
Gnomad SAS
AF:
0.890
Gnomad FIN
AF:
0.948
Gnomad MID
AF:
0.892
Gnomad NFE
AF:
0.924
Gnomad OTH
AF:
0.877
GnomAD2 exomes
AF:
0.890
AC:
188570
AN:
211900
AF XY:
0.896
show subpopulations
Gnomad AFR exome
AF:
0.840
Gnomad AMR exome
AF:
0.774
Gnomad ASJ exome
AF:
0.910
Gnomad EAS exome
AF:
0.860
Gnomad FIN exome
AF:
0.943
Gnomad NFE exome
AF:
0.927
Gnomad OTH exome
AF:
0.900
GnomAD4 exome
AF:
0.911
AC:
774943
AN:
851004
Hom.:
353640
Cov.:
11
AF XY:
0.911
AC XY:
406254
AN XY:
445710
show subpopulations
African (AFR)
AF:
0.843
AC:
17813
AN:
21142
American (AMR)
AF:
0.781
AC:
32054
AN:
41058
Ashkenazi Jewish (ASJ)
AF:
0.909
AC:
19763
AN:
21738
East Asian (EAS)
AF:
0.862
AC:
31164
AN:
36146
South Asian (SAS)
AF:
0.899
AC:
63267
AN:
70370
European-Finnish (FIN)
AF:
0.944
AC:
48546
AN:
51422
Middle Eastern (MID)
AF:
0.889
AC:
4057
AN:
4562
European-Non Finnish (NFE)
AF:
0.925
AC:
522333
AN:
564832
Other (OTH)
AF:
0.905
AC:
35946
AN:
39734
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
3561
7121
10682
14242
17803
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
7306
14612
21918
29224
36530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.889
AC:
135372
AN:
152198
Hom.:
60329
Cov.:
33
AF XY:
0.888
AC XY:
66111
AN XY:
74408
show subpopulations
African (AFR)
AF:
0.844
AC:
35045
AN:
41512
American (AMR)
AF:
0.823
AC:
12575
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.909
AC:
3156
AN:
3472
East Asian (EAS)
AF:
0.857
AC:
4439
AN:
5180
South Asian (SAS)
AF:
0.891
AC:
4294
AN:
4818
European-Finnish (FIN)
AF:
0.948
AC:
10056
AN:
10610
Middle Eastern (MID)
AF:
0.898
AC:
264
AN:
294
European-Non Finnish (NFE)
AF:
0.924
AC:
62821
AN:
68012
Other (OTH)
AF:
0.879
AC:
1859
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
775
1550
2324
3099
3874
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
904
1808
2712
3616
4520
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.904
Hom.:
11867
Bravo
AF:
0.879
Asia WGS
AF:
0.851
AC:
2933
AN:
3448

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sandhoff disease Benign:1
Jul 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.93
CADD
Benign
0.84
DANN
Benign
0.28
PhyloP100
-1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1665894; hg19: chr5-73992609; COSMIC: COSV54667778; API